Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer

NCT04046445 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
MSS
Stage IV Colon Cancer
Stage IV Rectal Cancer
Metastatic Colorectal Cancer
Liver Metastasis Colon Cancer

Interventions

DRUG: ATP128
DRUG: BI 754091
DRUG: VSV-GP128

Sponsor

Amal Therapeutics

Collaborators

[object Object]